Piermont Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Piermont Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-90,352	Closed	-$1.45M	–	273
2018 Q1	$1.45M	Buy	90,352 +1,980	+2%	+$39.2K	0.49%	96
2017 Q4	$1.68M	Sell	88,372 -64,820	-42%	-$1.17M	0.55%	88
2017 Q3	$2.15M	Sell	153,192 -94,690	-38%	-$857K	0.71%	67
2017 Q2	$1.85M	Sell	247,882 -64,960	-21%	-$424K	0.53%	71
2017 Q1	$2.03M	Sell	312,842 -36,060	-10%	-$202K	0.48%	90
2016 Q4	$1.55M	Sell	348,902 -27,860	-7%	-$117K	0.35%	116
2016 Q3	$1.76M	Sell	376,762 -3,500	-0.9%	-$20.7K	0.42%	95
2016 Q2	$2.5M	Buy	+380,262	New	+$2.69M	0.65%	62

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Piermont Capital Management's SPPI Position: Q2 2018 in Review

Piermont Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2018, closing a stake of 90,352 shares — an estimated $1.45M sold.

Piermont Capital Management first reported a position in SPPI in Q2 2016 and held it in 8 quarters. The position peaked at $2.5M in Q2 2016. 180 funds tracked by Wall St. Rank hold SPPI as of Q2 2018.

Piermont Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2018 after selling out during the quarter.
Piermont Capital Management sold 90,352 Spectrum Pharmaceuticals Inc shares in Q2 2018, an estimated $1.45M.
Piermont Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 8 quarters.
Piermont Capital Management's Spectrum Pharmaceuticals Inc position peaked at $2.5M in Q2 2016.
180 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2018.

Based on Piermont Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.